Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 2261
Gene Symbol: FGFR3
FGFR3
0.540 Biomarker disease CTD_human
Entrez Id: 6794
Gene Symbol: STK11
STK11
0.500 GeneticVariation disease UNIPROT
Entrez Id: 6794
Gene Symbol: STK11
STK11
0.500 Biomarker disease HPO
Entrez Id: 8626
Gene Symbol: TP63
TP63
0.350 GeneticVariation disease UNIPROT
Entrez Id: 7852
Gene Symbol: CXCR4
CXCR4
0.140 Biomarker disease HPO
Entrez Id: 1027
Gene Symbol: CDKN1B
CDKN1B
0.120 Biomarker disease HPO
Entrez Id: 6736
Gene Symbol: SRY
SRY
0.100 Biomarker disease HPO
Entrez Id: 6667
Gene Symbol: SP1
SP1
0.070 Biomarker disease BEFREE The production of early and term placental alkaline phosphatase (ALP), human chorionic gonadotropin beta-subunit (beta-hCG) and pregnancy-specific beta 1-glycoprotein (SP1) was confirmed in the newly established uterine cervical cancer call line SKG-IIIa. 6604031 1983
Entrez Id: 5673
Gene Symbol: PSG5
PSG5
0.020 Biomarker disease BEFREE Sodium butyrate produces concordant expression of "early placental" alkaline phosphatase, pregnancy-specific beta 1-glycoprotein and human chronic gonadotropin beta-subunit in a newly established uterine cervical cancer cell line (SKG-IIIa). 6604031 1983
Entrez Id: 653492
Gene Symbol: PSG10P
PSG10P
0.010 Biomarker disease BEFREE Sodium butyrate produces concordant expression of "early placental" alkaline phosphatase, pregnancy-specific beta 1-glycoprotein and human chronic gonadotropin beta-subunit in a newly established uterine cervical cancer cell line (SKG-IIIa). 6604031 1983
Entrez Id: 440533
Gene Symbol: PSG8
PSG8
0.010 Biomarker disease BEFREE Sodium butyrate produces concordant expression of "early placental" alkaline phosphatase, pregnancy-specific beta 1-glycoprotein and human chronic gonadotropin beta-subunit in a newly established uterine cervical cancer cell line (SKG-IIIa). 6604031 1983
Entrez Id: 3265
Gene Symbol: HRAS
HRAS
0.040 GeneticVariation disease BEFREE Somatic deletions and mutations of c-Ha-ras gene in human cervical cancers. 3060795 1988
Entrez Id: 3265
Gene Symbol: HRAS
HRAS
0.040 AlteredExpression disease BEFREE The addition of activated Ha-ras, an oncogene found in some cervical cancers expressing HPV16 or 18, to HPV16-immortalized human cervical cells results in malignancy as proven by the formation of cystic squamous cell carcinomas by HPV16-Ha-ras cells in nude mice. 2541388 1989
Entrez Id: 5243
Gene Symbol: ABCB1
ABCB1
0.040 Biomarker disease BEFREE In conclusion, our data suggest that the MDR1 gene plays a role in drug resistance of certain cervical cancers, but also that other mechanisms may be involved. 1697346 1990
Entrez Id: 23158
Gene Symbol: TBC1D9
TBC1D9
0.030 Biomarker disease BEFREE In conclusion, our data suggest that the MDR1 gene plays a role in drug resistance of certain cervical cancers, but also that other mechanisms may be involved. 1697346 1990
Entrez Id: 64218
Gene Symbol: SEMA4A
SEMA4A
0.010 AlteredExpression disease BEFREE To examine the correlations between ras oncogene expression and the development of cervical cancer, the authors studied the reactivity of cervical intraepithelial neoplasia (CIN) and microinvasive lesions of the human uterine cervix by using anti-ras p21 mouse monoclonal antibody rp35. 2196111 1990
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100 GeneticVariation disease BEFREE Structural alterations of the p53 gene were investigated in tissue specimens of gastric and cervical cancers and in cell lines of gastric, esophageal, and cervical cancers, by polymerase chain reaction-single-strand conformation polymorphism analysis. 1933850 1991
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100 GeneticVariation disease BEFREE Although a high incidence of HPV DNA integration and a low incidence of p53 mutation were confirmed in cancer of the uterine cervix, there was no inverse association between integration of HPV types 16 and/or 18 DNA and p53 mutation. 1336492 1992
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100 Biomarker disease BEFREE The inactivation of the wild-type p53 function resulting from a missense mutation, or the lack of detectable wild-type p53 protein due to the translational/post-translational deregulation of p53 protein levels may be the contributing factor in the tumorigenicity of these five cases of cervical cancer. 1322252 1992
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100 GeneticVariation disease BEFREE Properties of p53 mutations detected in primary and secondary cervical cancers suggest mechanisms of metastasis and involvement of environmental carcinogens. 1327751 1992
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100 GeneticVariation disease BEFREE This pattern of p53 mutation may partly explain the apparently worse prognosis of HPV-negative cervical cancers. 1349102 1992
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100 GeneticVariation disease BEFREE In this report, we have examined nine HPV-immortalized human cervical epithelial cell lines and 13 HPV-positive and two HPV-negative primary cervical cancers for p53 mutations by polymerase chain reaction--single-strand conformation polymorphism (PCR-SSCP). 8389030 1993
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100 GeneticVariation disease BEFREE It appears that p53 and Rb mutations are a very rare event in cervical cancer and their occurrence is apparently not strictly correlated with HPV status. 8384745 1993
Entrez Id: 4830
Gene Symbol: NME1
NME1
0.020 AlteredExpression disease BEFREE A strong association has been observed between reduced expression of Nm23 gene and acquisition of metastatic behaviour in some tumour cells including breast cancer and melanoma, but not in others such as colon cancer, neuroblastoma, and cervical cancer. 8394105 1993
Entrez Id: 8190
Gene Symbol: MIA
MIA
0.010 GeneticVariation disease BEFREE To elucidate the involvement of MK in the development of tumors, we further examined its expression in a variety of human neoplastic cell lines: YMB-1-C (breast cancer), EBC-1 (lung squamous cell carcinoma), RERF-LC-OK (lung adenocarcinoma), SBC-3 (lung small cell carcinoma), HSC-2 (mouth squamous cell carcinoma), NUGC-2 (gastric cancer), COLO201 (colon cancer), HepG2 (hepatoma), MIA PaCa-2 (pancreatic cancer), MCAS (ovarian cancer), HeLa (cervical cancer), BeWo (chorionic carcinoma), ITO-II (testicular tumor), T24 (urinary bladder tumor), and G-401 (Wilms' tumor). 8434639 1993